Comparison between Docmode Health Technologies IPO and Megatherm Induction IPO.
Docmode Health Technologies IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Megatherm Induction IPO is a SME Bookbuilding proposed to list at NSE SME.
| Docmode Health Technologies IPO | Megatherm Induction IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Fedex Securities Pvt.Ltd. | Hem Securities Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Rikhav Securities Ltd. | Hem Finlease Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Docmode Health Technologies IPO is up to ₹6.37 Cr whereas the issue size of the Megatherm Induction IPO is up to ₹51.20 Cr. The final issue price of Docmode Health Technologies IPO is ₹79.00 per share and of Megatherm Induction IPO is ₹108.00 per share.
| Docmode Health Technologies IPO | Megatherm Induction IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹100.00 per share | |
| Issue Price (Upper) | ₹108.00 per share | |
| Issue Price (Final) | ₹79.00 per share | ₹108.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 1600 shares | 1200 shares |
| Fresh Issue Size | 8,06,400 shares | 47,41,200 shares |
| Fresh Issue Size (Amount) | up to ₹6.37 Cr | up to ₹51.20 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 8,06,400 shares | 47,41,200 shares |
| Issue Size Total (Amount) | up to ₹6.37 Cr | up to ₹51.20 Cr |
Docmode Health Technologies IPO opens on Jan 25, 2024, while Megatherm Induction IPO opens on Jan 29, 2024. The closing date of Docmode Health Technologies IPO and Megatherm Induction IPO is Jan 30, 2024, and Jan 31, 2024, respectively.
| Docmode Health Technologies IPO | Megatherm Induction IPO | |
|---|---|---|
| Anchor Bid Date | Jan 25, 2024 | |
| Issue Open | Jan 25, 2024 | Jan 29, 2024 |
| Issue Close | Jan 30, 2024 | Jan 31, 2024 |
| Basis Of Allotment (Tentative) | Jan 31, 2024 | Feb 01, 2024 |
| Initiation of Refunds (Tentative) | Feb 01, 2024 | Feb 02, 2024 |
| Credit of Share (Tentative) | Feb 01, 2024 | Feb 02, 2024 |
| Listing date (Tentative) | Feb 02, 2024 | Feb 05, 2024 |
| Anchor Lockin End date 1 | Mar 02, 2024 | |
| Anchor Lockin End date 2 | May 01, 2024 |
Docmode Health Technologies IPO P/E ratio is 9.3, as compared to Megatherm Induction IPO P/E ratio of 10.68.
| Docmode Health Technologies IPO | Megatherm Induction IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 65.02 | 98.92 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 47.44 | 72.71 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 9.3 | 10.68 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹24.83 Cr. | ₹203.48 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 80.03% | 27.66% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 22.46% | 27.47% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 2.44 | 1.67 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹8.50 | ₹10.11 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 56.06% | 27.66% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Docmode Health Technologies IPO Retail Individual Investors (RII) are offered 4,03,200 shares while in Megatherm Induction IPO retail investors are offered 4,03,200 shares. Qualified Institutional Buyers (QIB) are offered in Docmode Health Technologies IPO and 9,48,000 shares in Megatherm Induction IPO.
| Docmode Health Technologies IPO | Megatherm Induction IPO | |
|---|---|---|
| Anchor Investor Reservation | 14,22,000 shares | |
| Market Maker Reservation | 43,200 shares | 2,50,800 shares |
| QIB | 9,48,000 shares | |
| NII | 4,03,200 shares | 7,11,600 shares |
| RII | 4,03,200 shares | 16,59,600 shares |
| Employee | ||
| Others | ||
| Total | 8,06,400 shares | 47,41,200 shares |
Docmode Health Technologies IPO subscribed 215.24x in total, whereas Megatherm Induction IPO subscribed 196.11x.
| Docmode Health Technologies IPO | Megatherm Induction IPO | |
|---|---|---|
| QIB (times) | 105.14x | |
| NII (times) | 194.90x | 307.04x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 230.38x | 200.51x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 215.24x | 196.11x |
